These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19659504)

  • 1. Pharmacokinetics and safety of olmesartan medoxomil in combination with either amlodipine or atenolol compared to respective monotherapies in healthy subjects.
    Bolbrinker J; Huber M; Scholze J; Kreutz R
    Fundam Clin Pharmacol; 2009 Dec; 23(6):767-74. PubMed ID: 19659504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amlodipine and olmesartan after administration of amlodipine besylate and olmesartan medoxomil in separate dosage forms and as a fixed-dose combination.
    Rohatagi S; Lee J; Shenouda M; Haworth S; Bathala MS; Allison M; Rubets I; Heyrman R; Noveck R; Salazar DE
    J Clin Pharmacol; 2008 Nov; 48(11):1309-22. PubMed ID: 18974285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of olmesartan medoxomil in combination with glibenclamide in healthy volunteers.
    Huber M; Bolbrinker J; Kreutz R
    Clin Exp Hypertens; 2006 Oct; 28(7):631-43. PubMed ID: 17060062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of olmesartan medoxomil plus hydrochlorothiazide combination in healthy subjects.
    Kreutz R; Bolbrinker J; Huber M
    Clin Drug Investig; 2006; 26(1):29-34. PubMed ID: 17163232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
    Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
    Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
    Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
    Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations.
    Jiang J; Liu D; Hu P
    Pharmazie; 2009 May; 64(5):323-6. PubMed ID: 19530443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
    Yi S; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):682-9. PubMed ID: 21394036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of population pharmacokinetics and exposure-response relationship with coadministration of amlodipine besylate and olmesartan medoxomil.
    Rohatagi S; Carrothers TJ; Kshirsagar S; Khariton T; Lee J; Salazar D
    J Clin Pharmacol; 2008 Jul; 48(7):823-36. PubMed ID: 18490496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of colesevelam HCl on the single-dose pharmacokinetics of glimepiride, extended-release glipizide, and olmesartan medoxomil.
    He L; Wickremasingha P; Lee J; Tao B; Mendell-Harary J; Walker J; Wight D
    J Clin Pharmacol; 2014 Jan; 54(1):61-9. PubMed ID: 24019110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of repeated oral doses of amlodipine and amlodipine plus telmisartan in healthy volunteers.
    Stangier J; Su CA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1347-54. PubMed ID: 11185633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of olmesartan medoxomil plus hydrochlorothiazide combination in healthy Chinese subjects: drug-drug interaction, bioequivalence, and accumulation.
    Liu DY; Jiang J; Wang CG; Zhang JY; Hu P
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):321-7. PubMed ID: 24472401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects.
    Oh M; Shin JG; Ahn S; Kim BH; Kim JY; Shin HJ; Shin HJ; Ghim JL
    Drug Des Devel Ther; 2019; 13():991-997. PubMed ID: 31114155
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects.
    Lee SY; Kim JR; Jung JA; Huh W; Bahng MY; Ko JW
    Drug Des Devel Ther; 2015; 9():2811-7. PubMed ID: 26082611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a population pharmacokinetic model to describe olmesartan medoxomil/ hydrochlorothiazide (20/12.5 mg) FDC tablet in male healthy South Korean subjects.
    Chae JW; Baek IH; Seo JW; Jung SH; Back HM; Song BJ; Lee BY; Yun HY; Kang W; Kwon KI
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):676-83. PubMed ID: 24849193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.